Cargando…
Customized liver organoids as an advanced in vitro modeling and drug discovery platform for non-alcoholic fatty liver diseases
Non-alcoholic fatty liver disease (NAFLD) and its progressive form non-alcoholic steatohepatitis (NASH) have presented a major and common health concern worldwide due to their increasing prevalence and progressive development of severe pathological conditions such as cirrhosis and liver cancer. Alth...
Autores principales: | Han, Dong Wook, Xu, KangHe, Jin, Zhe-Long, Xu, Yong-Nan, Li, Ying-Hua, Wang, Lin, Cao, Qilong, Kim, Kee-Pyo, Ryu, DongHee, Hong, Kwonho, Kim, Nam-Hyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10367556/ https://www.ncbi.nlm.nih.gov/pubmed/37497008 http://dx.doi.org/10.7150/ijbs.85145 |
Ejemplares similares
-
Production of Highly Uniform Midbrain Organoids from Human Pluripotent Stem Cells
por: Yao, Xuerui, et al.
Publicado: (2023) -
Emerging liver organoid platforms and technologies
por: Lam, Do Thuy Uyen Ha, et al.
Publicado: (2021) -
CRISPR-edited hepatic organoids as drug screening platform for non-alcoholic fatty liver disease
por: Wang, Yinhan, et al.
Publicado: (2023) -
Artesunate and sorafenib: Combinatorial inhibition of liver cancer cell growth
por: Li, Hao, et al.
Publicado: (2019) -
Liver organoids: an in vitro 3D model for liver cancer study
por: Dong, Renshun, et al.
Publicado: (2022)